| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Fourth Quarter and Full Year 2023 Guidance
| Fourth Quarter 2023 | Full Year 2023 | ||||||||||
| Revenue | $98.5 million | $367.6 million | |||||||||
| Year-over-Year Growth % | ~19% | ~21% | |||||||||
| Adjusted EBITDA | $28 million | $104 million | |||||||||
| Adjusted EBITDA Margin % | ~28% | ~28% | |||||||||
| Equity-based compensation expense and related payroll taxes | ~$80 million | ||||||||||
| Equity-based compensation expense related to JUMP Technology acquisition | ~$25 million | ||||||||||
| Depreciation and Amortization | ~$9 million | ||||||||||
| Non-GAAP effective tax rate | 25% | ||||||||||
| Diluted non-GAAP share count | ~255 million | ||||||||||
Certain components of the guidance given above are provided on a non-GAAP basis only without providing a reconciliation to guidance provided on a GAAP basis. Information is presented in this manner because the preparation of such a reconciliation could not be accomplished without "unreasonable efforts." The Company does not have access to certain information that would be necessary to provide such a reconciliation, including non-recurring items that are not indicative of the Company's ongoing operations. The Company does not believe that this information is likely to be significant to an assessment of the Company's ongoing operations.
Posted In: CWAN
